Journal of The Academy of Clinical Microbiologists

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  26 (2024)
Volume  25 (2023)
Volume  24 (2022)
Volume  23 (2021)
Volume  22 (2020)
Volume  21 (2019)
Volume  20 (2018)
Volume  19 (2017)
Volume  18 (2016)
Volume  17 (2015)
Volume  16 (2014)
Volume  15 (2013)
Related articles

VOLUME 19 , ISSUE 2 ( July-December, 2017 ) > List of Articles

SHORT COMMUNICATION

Role of cartridge-based nucleic acid amplification test in detection of pulmonary tuberculosis in people living with human immunodeficiency virus

Rajneesh Tripathi, Sumedha Kashyap, Prince Chaubey, Alok Prakash Pandey, Shampa Anupurba

Keywords : Cartridge-based nucleic acid amplification test, People living with human immunodeficiency virus, Revised National Tuberculosis Control Program, Tuberculosis

Citation Information : Tripathi R, Kashyap S, Chaubey P, Pandey AP, Anupurba S. Role of cartridge-based nucleic acid amplification test in detection of pulmonary tuberculosis in people living with human immunodeficiency virus. 2017; 19 (2):114-117.

DOI: 10.4103/jacm.jacm_37_16

License: CC BY-NC 4.0

Published Online: 17-08-2024

Copyright Statement:  Copyright © 2017; Wolters Kluwer India Pvt. Ltd.


Abstract

INTRODUCTION: Tuberculosis (TB) in human immunodeficiency virus (HIV)-infected people remains a major global public health challenge. Cartridge-based nucleic acid amplification test (CBNAAT) has been proved to have a key role in diagnosing TB in patients having HIV infection. METHOD: In this study, we intend to present a retrospective data of HIV-TB co-infected patients during our routine diagnostic algorithm under Revised National TB Control Program (RNTCP). RESULT: A total of 59/207 (28.8%) HIV patients were diagnosed to be positive for TB by CBNAAT in the period January to December 2015.

PDF Share
  1. World Health Organization. Global Tuberculosis Report 2014. Geneva: World Health Organization; 2014. Available from: http://www.apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf. [Last accessed on 2016 Apr 15].
  2. Ministry of Health, Government of India, TB India 2014, Revised National TB Control Programme, Annual Status Report, Central TB Division. New Delhi: MOH, GOI; 2014. [Last accessed on 2016 Apr 25].
  3. World Health Organization. Automated Real-Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update; 2013. Geneva: 2013. Available from: http://www.apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf. [Last accessed on 2016 Apr 15].
  4. Weyer K, Mirzayev F, Migliori GB, Gemert WV, D'Ambrosio L, Zignol M, et al. Rapid molecular TB diagnosis: Evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 2013;42:252-71.
  5. World Health Organization. Xpert MTB/RIF for People Living with HIV 2014. Geneva: World Health Organization; 2014. Available from: http://www.who.int/tb/challenges/hiv/Xpert_TBHIV_Information_Note_final.pdf. [Last assessed on 2015 Nov 01].
  6. Walusimbi S, Bwanga F, De Costa A, Haile M, Joloba M, Hoffner S, et al. Meta-analysis to compare the accuracy of geneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis 2013;13:507.
  7. World Health Organization India, Standards for TB Care in India 2014. Available from: http://www.clinicalestablishments.nic.in/WriteReadData/93.pdf. [Last accessed on 2016 Apr 15].
  8. Central TB Division Ministry of Health and Family Welfare, New Delhi, India. Revised National TB Control Programme. Guidelines for Programmatic Management of Drug Tuberculosis (India), Updated May, 2012. Available from: http://www.tbcindia.nic.in/docs/pdf. [Last accessed on 2016 Apr 15].
  9. World Health Organization. Policy Statement: Automated Real Time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System, 2014. Available from: http://www.WHO/HTM/TB/2011.4. [Last accessed on 2016 Apr 25].
  10. Bhushan B, Kajal NC, Maske A, Nadia, Bharti H, Singh J. Tuberculosis in HIV co-infected patients – A study at tertiary care hospital, Amritsar (India). Indian J Tuberc 2013;60:202-7.
  11. Sharma SK, Soneja M, Prasad KT, Ranjan S. Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in North India. Indian J Med Res 2014;139:154-60.
  12. Sethi S, Mewara A, Dhatwalia SK, Singh H, Yadav R, Singh K, et al. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in North India. BMC Infect Dis 2013;13:137.
  13. Arora D, Jindal N, Bansal R, Arora S. Rapid detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert assay: A clinical study. J Clin Diagn Res 2015;9:DC03-5.
  14. Raizada N, Sachdeva KS, Sreenivas A, Kulsange S, Gupta RS, Thakur R, et al. Catching the missing million: Experiences in enhancing TB & DR-TB detection by providing upfront xpert MTB/RIF testing for people living with HIV in India. PLoS One 2015;10:e0116721.
  15. Raizada N, Sachdeva KS, Nair SA, Kulsange S, Gupta RS, Thakur R, et al. Enhancing TB case detection: Experience in offering upfront xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB. PLoS One 2014;9:e105346.
  16. Singh AK, Karmakar D, Jha AK. Compararative Accuracy of geneXpert/CBNAAT (Cartridge Based Nucleic Acid Amplification test)-TB and Sputum Microscopy in Diagnosis of Pulmonary Tuberculosis in HIV Positive Patients and a Meta Analysis of Existing Literature. Conference: ASICON 2013: National CME, at Kolkata; 2013.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.